Alison Goate

Alison Mary Goate is the Jean C. and James W. Crystal Professor and Chair of the Department of Genetics and Genomic Sciences and Director of the Loeb Center for Alzheimer's Disease at Icahn School of Medicine at Mount Sinai, New York City. She was previously professor of genetics in psychiatry, professor of genetics, and professor of neurology at Washington University School of Medicine.

The Goate Lab studies the genetics and molecular bases of Alzheimer's disease, frontotemporal dementia, and alcoholism.

Education and early career
After receiving her undergraduate degree in biochemistry at the University of Bristol (UK) and her graduate training at Oxford University (UK), Goate studied under Professors Theodore Puck, Professor Louis Lim and Dr. John Hardy. She received a Royal Society University Research Fellowship to conduct research at St. Mary's Hospital Medical School in London.

Awards and affiliations
She has received the Potamkin Prize from the American Academy of Neurology (1993), the Zenith Award from the Alzheimer's Association, Senior Investigator Award from the Metropolitan Life Foundation, the St. Louis Academy of Science Innovation Award, Carl and Gerty Cori Faculty Achievement Award at Washington University in St. Louis. (1994), and a Lifetime Achievement Award from the Alzheimer's Association (2015). She is a fellow of the American Association for the Advancement of Science. She also serves on the faculty of the Hope Center for Neurological Disorders and is an elected member of the National Academy of Medicine. Dr. Goate received the Rainwater Prize for Innovation in Neurodegeneration from the Rainwater Charitable Foundation in 2022. Dr. Goate was the first female to be awarded the Piepenbrock-DZNE Prize for Neurodegenerative disease research in 2023.

Research
Goate's research centers on the genetics of Alzheimer's disease and related dementias that led to the development of animal and cellular models and the development of anti-amyloid and anti-tau therapies. She has been the principal investigator on four grants and has co-invented and awarded six patents.

Patents

 * APP770 mutant in alzheimer's disease, (1999).
 * Mutant S182 genes, (1999).
 * Method for elucidation and detection of polymorphisms, splice variants, and proximal coding mutations using intronic sequences of the Alzheimer's S182 gene, (2000).
 * Transgenic mouse expressing an APP-FAD DNA sequence, (2001).
 * Pathogenic Tau mutations, (2002).
 * Markers for addiction, (2011).

Grants
Partial list:

Publications
Semantic Scholar lists 483 publications, 22,943 citations and 1,808 influential citations of Goate's peer-reviewed and original contribution as of 2019.

Partial list:
 * Cited by 5017 as of October 18, 2019.
 * Cited by 2274 as of October 18, 2019.
 * Cited by 793 as of October 18, 2019
 * Cited by 604 as of October 18, 2019.
 * Cited by 419 as of October 18, 2019
 * Cited by 275 as of October 18, 2019.
 * Bierut LJ et al. (2012) "ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry." Mol Psychiatry PMCID: PMC3252425.
 * Hutton M., et al. (1998) "Association of missense and 5’-splice-site mutations in tau with inherited dementia FTDP-17." Nature PMID 9641683.
 * Gitcho M, et al. (2008) "TDP-43 A 315T mutation in familial motor neuron disease." Ann Neurol PMCID: PMC2747362
 * Kauwe JSK, et al. (2008). "Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition." Proc Natl Acad Science PMCID: PMC2430357.
 * Bierut L J, et al. (2008). "Variants in nicotinic receptors and risk for nicotine dependence." Am J Psychiatry PMCID: PMC2574742
 * Guerreiro R et al.; (2013) "TREM2 Variants in Alzheimer's Disease" NEJM PMCID: PMC3631573.
 * Cruchaga C. et al.; (2013) "GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease." Neuron PMCID: PMC3664945
 * Cruchaga C. (2014). "Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease." Nature PMCID: PMC4050701.
 * Kauwe JS. et al. (2014) "Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation." PLoS Genet. PMCID: PMC4207667.
 * Huang KL, et al. (2017). "A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease." Nat Neuroscience PMCID: PMC5759334.
 * Kapoor M, et al. (2019). "Analysis of whole genome-transcriptomic organization in brain to identify genes associated with alcoholism." Transl Psychiatry PMCID: PMC6376002.
 * Novikova G, et al. (2021). "Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes." Nat Commun PMID: 33712570.
 * Kapoor M, et al. (2021). "Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases." Nat Commun. PMID: 34417470.
 * Bowles KR, et al. (2021). "ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids." Cell. PMID: 34314701.
 * Tcw J, et al. (2022). "Cholesterol and matrisome pathways dysregulated in astrocytes and microglia." Cell. PMID 35750033.
 * Podleśny-Drabiniok A, et al. (2024) "BHLHE40/41 regulate microglia and peripheral macrophage responses associated with Alzheimer's disease and other disorders of lipid-rich tissues." Nat Commun. PMID 38448474.